Dynavax Technologies Corp (DVAX)
13.02
+0.18
(+1.40%)
USD |
NASDAQ |
Dec 26, 16:00
13.10
+0.08
(+0.61%)
After-Hours: 20:00
Dynavax Technologies Market Cap: 1.712B for Dec. 26, 2024
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Biogen Inc | 21.85B |
| Repligen Corp | 8.160B |
| West Pharmaceutical Services Inc | 24.13B |
| Amicus Therapeutics Inc | 2.921B |
| Janux Therapeutics Inc | 2.893B |
Market Cap Related Metrics
| PE Ratio | 100.15 |
| PS Ratio | 7.100 |
| Price to Book Value | 2.512 |
| Price to Free Cash Flow | 81.68 |
| Price | 13.02 |
| Earnings Yield | 1.00% |
| Normalized PE Ratio | 100.15 |